Effect of imipramine treatments on the 5-HT1(A)-receptor-mediated inhibition of panic-like behaviours in rats

Psychopharmacology

Volumn 131, Issue 4, 1997, Pages 321-328

  Mongeau, Raymond ^a   Marsden, Charles A ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Animal model; Anxiety; Panic disorder; Periaqueductal grey; Serotonergic system; Tricyclic antidepressant drugs

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; HOMOCYSTEIC ACID; IMIPRAMINE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESCAPE BEHAVIOR; FLIGHT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; BEHAVIOR, ANIMAL; ESCAPE REACTION; HOMOCYSTEINE; IMIPRAMINE; MALE; PANIC DISORDER; RATS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030814703     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050299     Document Type: Article

References (62)

1. Audi EA, de Aquiar JC, Graeff FG (1988) Mediation by serotonin of the antiaversive effect of zimelidine and propanolol injected into the dorsal midbrain central grey. J Psychopharmacol 2:26-32
2. Bandler R (1988) Brain mechanisms of aggression as revealed by electrical and chemical stimulation: suggestion of a central role for the midbrain periacqueductal grey region. In: Epstein AN, Morrison R (eds) Progress in psychobiology and physiological psychology. Academic Press, New York, pp 67 154
3. Beardslee SL, Papadakis E, Fontana DJ, Commissaris RL (1990) Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior. Pharmacol Biochem Behav 35:451 455
4. Beaumont G (1977) A large, open multicentre trial of clomipramine (Anafranil) in the management of phobic disorders. J Int Med Res 5:116 124
5. Beckett S, Marsden CA (1995) Computer analysis and quantification of periaqueductal grey-induced defence behaviour. J Neurosci Meth 58:157 161
6. 1 receptor agonists administered into the periaqueductal gray. Psychopharmacology 108:110 114
7. 1A receptors inhibits midbrain periaqueductal gray neurons of the rat. Brain Res 612:56 60
8. Beitz AJ, Clements JR, Mullett M, Ecklund L (1986) Differential origin of brainstem serotonergic projections to the midbrain periaqueductal gray and superior colliculus of the rat. J Comp Neurol 250:498-509
9. 1 neurons to serotonin ex vivo. Pol J Pharmacol 46:163 167
10. Blanchard RJ, Shepherd JK, Rodgers RJ, Magee L, Blanchard DC (1993) Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine. Psychopharmacology 110:245-253
11. Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ (1988) The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 95: 298 302
12. 1A receptors on neurones of the rat midbrain tectum. Brain Res 556:259 266
13. Cassella JV, Davis M (1985) Fear-enhanced acoustic starle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology 87:278-282
14. Chaput Y, de Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments: an in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5: 219-229
15. Cole JC, Rodgers RJ (1995) Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473 478
16. Coplan JD, Gorman JM, Klein DF (1992) Serotonin related functions in panic-anxiety: a critical overview. Neuropsychopharmacology 6:189-200
17. de Montigny C, Aghajanian GK (1978) Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202:1303 1306
18. Deakin JF, Graeff FG, Guimaraes F (1992) 5-HT receptor subtypes and the modulation of aversion. In: Marsden C, Heal DJ (eds) Central serotonin receptors and psychotropic drugs. Blackwell, London, pp 147-174
19. File SE, Johnston AL (1987) Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat. Neuropsychobiology 17:187-192
20. Fontana DJ. Commissaris RL (1988) Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder? Psychopharmacology 95:147-150
21. Graeff FG (1990) Brain defense systems and anxiety. In: Burrows GD, Roth M, Noyes R (eds) Handbook of anxiety: the neurobiology of anxiety. Elsevier, Amsterdam, pp 307 354
22. Graeff FG, Silveira MC, Nogueira RL, Audi EA, Oliveira RM (1993) Role of the amygdala and periaqueductal gray in anxiety and panic. Behav Brain Res 58:123-131
23. 2 receptor number in frontal cortex. Br J Pharmacol 80:377 385
24. Griebel G, Blanchard DC, Agnes RS, Blanchard RJ (1995) Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 120: 57-66
25. Hendrie CA, Neill JC (1991) An animal model of panic disorder. J Psychopharmacol 6:125
26. 1A receptor regulation. Effect of 5.7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131 144
27. Hodges H, Greens S, Glenn B (1987) Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not in discrimination. Psychopharmacology 92:491-504
28. 1c) receptors on periaqueductal gray aversion. Eur J Pharmacol 161:219 221
29. 3 receptors. Psychopharmacology 97:489 495
30. Jenck F, Broekkamp CLE, Van Delft AML (1990a) The effect of antidepressants on aversive periaqueductal gray stimulation in rats. Eur J Pharmacol 177:201-204
31. 1c receptors in the serotonergic control of periaqueductal gray induced aversion in rats. Psychopharmacology 100: 372 376
32. Jenck F, Moreau J-L, Martin JR (1995) Dorsal periaqueductal grayinduced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res 57:181-191
33. 1A autoregulatory control of 5-HT release in rat brain in vivo. J Neurosci Meth 34: 91-98
34. Kiser RS, Lebovitz RM (1975) Monoaminergic mechanisms in aversive brain stimulation. Physiol Behav 15:47 53
35. Kiser RS, German DC, Lebovitz RM (1978) Serotonergic reduction of dorsal central gray area stimulation-produced aversion. Pharmacol Biochem Behav 9:27
36. Kiser RS, Brown CA, Sanghera MK, German DC (1980) Dorsal raphe stimulation reduces centrally elicited fear-like behaviour. Brain Res 191:265 272
37. Klein DF (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5:397-408
38. Kwiat GC, Basbaum AI (1990) Organization of tyrosine hydroxylase- and serotonin-immunoreactive brainstem neurons with axon collaterals to the periaqueductal gray and the spinal cord in the rat. Brain Res 528:83 94
39. Lesch K-P, Manji HK (1992) Signal-transducing G proteins and antidepressant drugs: evidence for modulation of a subunit gene expression in rat brain. Biol Psychiatry 32:549 579
40. 2 receptor binding sites. Binding properties, brain distribution and functional role. Mol Pharmacol 21:301 314
41. Lovick TA (1993) Serotonergic influence from nucleus raphe obscurus on neurones in the periaqueductal grey matter in the rat. Brain Res 606:92 98
42. Lovick TA (1994) Influence of the dorsal and median raphe nuclei on neurons in the periaqueductal gray matter: role of 5-hydroxytryptamine. Neuroscience 59:993 1000
43. Mavissakalian MR, Perel JM (1989) Imipramine dose-response relationship in panic disorder with agoraphobia. Arch Gen Psychiatry 46:127 131
44. Mavissakalian MR, Perel JM (1992) Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. Am J Psychiatry 149:1053-1057
45. Mongeau R, Marsden CA (1996) Effect of central and peripheral administrations of CCK-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat. Biol Psychiatry (in press)
46. Muskin PR, Fryer AJ (1981) Treatment of panic disorder. J Clin Psychopharmacol 1:81-90
47. Nashold BS, Wilson WP, Slaughter DG (1969) Sensations evoked by stimulation of the midbrain of man. J Neurosurg 30: 14-24
48. Noyes R, Garvey MJ, Cook BL, Samuelson L (1989) Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatry 50:163-169
49. Olds ME, Olds J (1963) Approach-avoidance analysis of rat diencephalon. J Comp Neurol 120:259-295
50. Paxinos A, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
51. Pecknold JC, McClure DJ, Appeltauer L et al (1982) Does tryptophan potentiate clomipramine in the treatment of agoraphobic and social phobic patients? Br J Psychiatry 140:484 490
52. Pellow S, File SE (1987) Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA - benzodiazepine receptor complex? Neuropsychobiology 17:60 65
53. Schutz MTB, De Aguiar JC, Graeff FG (1985) Anti-aversive role of serotonin on the dorsal periaqueductal gray matter. Psychopharmacology 85:340-345
54. Schvarcz JR (1975) Periaqueductal mesencephalotomy for facial central pain. In: Neurosurgical treatment in psychiatry, pain and epilepsy. University Park Press, Baltimore, Md., pp661 668
55. Sheehan DV, Ballenger J, Jacobson G (1980) Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch Gen Psychiatry 37:51 59
56. Stezhka VV. Lovick TA (1994) Inhibitory and excitatory projections from the dorsal raphe nucleus to neurons in the dorsolateral periaqueductal gray matter in slices of midbrain maintained in vitro. Neuroscience 62:177 187
57. Stolz JF, Marsden CA (1982) Withdrawal from chronic treatment with metergoline, dl-propanolol and amitriptyline enhance serotonin receptor mediated behaviour in the rat. Eur J Pharmacol 79:17-22
58. 3H]-spiperone binding in rat frontal cortex and serotonin mediated behaviour. Psychopharmacology 80:150 155
59. Valenstein ES (1965) Independence of approach and escape reactions to electrical stimulation of the brain. J Comp Physiol Psychol 60:20 30
60. Wang RY, Aghajanian GK (1980) Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment. Commun Psychopharmacol 4:83-90
61. o-type GTP binding protein by tricyclic antidepressants. Neurosci Lett 139:194 196
62. Zitrin CM, Klein DF, Woerner MG et al (1980) Treatment of agoraphobia with group exposure, in vivo and imipramine. Arch Gen Psychiatry 37:63 72